A Novel Molecular Classification Method for Glioblastoma Based on Tumor Cell Differentiation Trajectories
暂无分享,去创建一个
Wangli Zhou | Qiang Li | Zifu Li | N. Lv | Luojiang Zhu | Guanghao Zhang | Jianmin Liu | Jing Wang | Rundong Chen | Xiao-lu Xu | Sisi Li | P. Yang
[1] F. Paris,et al. Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma , 2021, Oncogene.
[2] Stephen R. Williams,et al. A single-cell and spatially resolved atlas of human breast cancers , 2021, Nature Genetics.
[3] Jia Fan,et al. Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis , 2021, Journal for ImmunoTherapy of Cancer.
[4] C. Qian,et al. Role and mechanism of neural stem cells of the subventricular zone in glioblastoma , 2021, World journal of stem cells.
[5] D. Lambrechts,et al. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification , 2021, Genome Medicine.
[6] G. Reifenberger,et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.
[7] M. Glatzel,et al. Differential expression of stem cell markers in proliferating cells in glioma , 2021, Journal of Cancer Research and Clinical Oncology.
[8] Yue Yu,et al. Upregulation of HOXC9 generates interferon‐gamma resistance in gastric cancer by inhibiting the DAPK1/RIG1/STAT1 axis , 2021, Cancer science.
[9] M. Dymova,et al. Molecular Mechanisms of Drug Resistance in Glioblastoma , 2021, International journal of molecular sciences.
[10] C. Verfaillie,et al. SOX9-induced Generation of Functional Astrocytes Supporting Neuronal Maturation in an All-human System , 2021, Stem Cell Reviews and Reports.
[11] F. Santilli,et al. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy , 2021, International journal of molecular sciences.
[12] F. Guilak,et al. Single cell transcriptomic analysis of human pluripotent stem cell chondrogenesis , 2021, Nature Communications.
[13] E. Mandonnet,et al. Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma , 2021, Journal of Cancer Research and Clinical Oncology.
[14] C. Jun,et al. Potentiating the Antitumor Activity of Cytotoxic T Cells via the Transmembrane Domain of IGSF4 That Increases TCR Avidity , 2021, Frontiers in Immunology.
[15] W. Yung,et al. Molecular Mechanisms of Treatment Resistance in Glioblastoma , 2020, International journal of molecular sciences.
[16] G. Reifenberger,et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood , 2020, Nature Reviews Clinical Oncology.
[17] J. Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. , 2020, Neuro-oncology.
[18] Dan Xu,et al. Identification of a novel cancer stem cell subpopulation that promotes progression of human fatal renal cell carcinoma by single-cell RNA-seq analysis , 2020, International journal of biological sciences.
[19] Xinghua Pan,et al. Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing , 2020, Molecular cancer.
[20] A. Ratan,et al. Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation , 2020, Genome Biology.
[21] R. Seiler,et al. Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications , 2020, International journal of molecular sciences.
[22] F. Tang,et al. Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies , 2020, National science review.
[23] Jung-Il Lee,et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma , 2020, Nature Communications.
[24] E. Lesser,et al. Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis , 2020, Journal of Neuro-Oncology.
[25] B. Pang,et al. Single‐cell RNA‐seq reveals the invasive trajectory and molecular cascades underlying glioblastoma progression , 2019, Molecular oncology.
[26] K. Debatin,et al. Temozolomide and Other Alkylating Agents in Glioblastoma Therapy , 2019, Biomedicines.
[27] C. Gupta,et al. Advancements in Cancer Stem Cell Isolation and Characterization , 2019, Stem Cell Reviews and Reports.
[28] Christopher M. Jackson,et al. Mechanisms of immunotherapy resistance: lessons from glioblastoma , 2019, Nature Immunology.
[29] Jong-Hee Chang,et al. Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma , 2019, Scientific Reports.
[30] Hector Roux de Bézieux,et al. Trajectory-based differential expression analysis for single-cell sequencing data , 2019, Nature Communications.
[31] B. Popko,et al. Molecular Control of Oligodendrocyte Development , 2019, Trends in Neurosciences.
[32] A. Ciccodicola,et al. Transcriptional Regulation: Molecules, Involved Mechanisms, and Misregulation , 2019, International journal of molecular sciences.
[33] A. Lerário,et al. CD99 Expression in Glioblastoma Molecular Subtypes and Role in Migration and Invasion , 2019, International journal of molecular sciences.
[34] Z. Storchová,et al. Modelling chromosome structural and copy number changes to understand cancer genomes. , 2019, Current opinion in genetics & development.
[35] S. Spiegl-Kreinecker,et al. Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature , 2018, Journal of cellular and molecular medicine.
[36] Marzieh Ebrahimi,et al. Glioblastoma cancer stem cell biology: Potential theranostic targets. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[37] Eunjee Lee,et al. Comparison of glioblastoma (GBM) molecular classification methods. , 2018, Seminars in cancer biology.
[38] J. Henley,et al. The transcription factor MEF2A plays a key role in the differentiation/maturation of rat neural stem cells into neurons , 2018, Biochemical and biophysical research communications.
[39] Z. Kozmík,et al. Tcf7L2 is essential for neurogenesis in the developing mouse neocortex , 2018, Neural Development.
[40] Shane A. Evans,et al. Regulation of Cellular Senescence by Polycomb Chromatin Modifiers through Distinct DNA Damage-and Histone Methylation-Dependent Pathways , 2018, Cell reports.
[41] Yupei Zhao,et al. CD59: a promising target for tumor immunotherapy. , 2018, Future oncology.
[42] S. Hansen,et al. Tumour‐associated microglia/macrophages predict poor prognosis in high‐grade gliomas and correlate with an aggressive tumour subtype , 2018, Neuropathology and applied neurobiology.
[43] Edward F. Chang,et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. , 2017, Cancer cell.
[44] F. Xia,et al. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition , 2017, Journal of experimental & clinical cancer research : CR.
[45] David T. W. Jones,et al. H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers , 2017, Acta Neuropathologica.
[46] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[47] C. Wirtz,et al. CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells , 2016, Cell Death and Disease.
[48] F. Ginhoux,et al. Tissue-Resident Macrophage Ontogeny and Homeostasis. , 2016, Immunity.
[49] Steven J. M. Jones,et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma , 2016, Cell.
[50] Yuyuan Dai,et al. Inhibition of Autophagy by Chloroquine Enhances the Antitumor Efficacy of Sorafenib in Glioblastoma , 2016, Cellular and Molecular Neurobiology.
[51] J. Rich,et al. Cancer stem cells in glioblastoma , 2015, Genes & development.
[52] T. Ishikawa. Genetic polymorphism in the NRF2 gene as a prognosis marker for cancer chemotherapy , 2014, Front. Genet..
[53] Shawn M. Gillespie,et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.
[54] Lei Han,et al. Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. , 2012, Neuro-oncology.
[55] Eric A Bushong,et al. Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice , 2012, Science.
[56] S. González,et al. Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest. , 2012, Cell stem cell.
[57] Ana Lluch,et al. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. , 2012, Cancer treatment reviews.
[58] A. Aguilar-Lemarroy,et al. MEIS1, PREP1, and PBX4 Are Differentially Expressed in Acute Lymphoblastic Leukemia: Association of MEIS1 Expression with Higher Proliferation and Chemotherapy Resistance , 2011, Journal of experimental & clinical cancer research : CR.
[59] J. Frampton. Mifamurtide: a review of its use in the treatment of osteosarcoma. , 2010, Paediatric drugs.
[60] T. Kume,et al. The Foxc2 transcription factor regulates tumor angiogenesis. , 2010, Biochemical and biophysical research communications.
[61] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[62] M. J. van den Bent,et al. Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma , 2009, British Journal of Cancer.
[63] B. Neyns,et al. Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[64] C. James,et al. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. , 2000, Cancer research.